Gregory D. Williams
General Counsel at Emulate, Inc.
Gregory D. Williams active positions
| Companies | Position | Start | End |
|---|---|---|---|
Emulate, Inc.
 Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | General Counsel | - | - |
Career history of Gregory D. Williams
Former positions of Gregory D. Williams
| Companies | Position | Start | End |
|---|---|---|---|
New England Biolabs, Inc.
 New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | General Counsel | - | - |
Training of Gregory D. Williams
| McGill University | Graduate Degree |
| The University of Pennsylvania Law School | Graduate Degree |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| General Counsel | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Process Industries | 2 |
| Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
New England Biolabs, Inc.
New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Process Industries |
Emulate, Inc.
Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Retail Trade |
- Stock Market
- Insiders
- Gregory D. Williams
- Experience
